Top Markets
#1 Black Phoenix Black Phoenix +355.71%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +57.01%
#4 Gold Park Gold Park +55.15%
#5 Acurast Acurast +28.90%
#6 BasedHype BasedHype +28.38%
#7 Cryptopia Cryptopia +22.67%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#9 Avantis Avantis +16.65%
#10 HOME HOME +15.01%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
In Veritas Medical Diagnostics, Inc. In Veritas Medical Diagnostics, Inc.

In Veritas Medical Diagnostics, Inc.

IVME
Rank in Stocks #41111
In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its... In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also actively developing an array of other diagnostic tools. These include a consumer-oriented device to predict the onset of labor for maternity planning, a comprehensive biomarker monitor capable of identifying indicators for conditions such as heart attacks, HIV, cholesterol levels, and cancer. Further innovations under development feature a non-invasive device for continuous blood glucose concentration measurement, a digital scanning machine designed as a non-invasive alternative to traditional 2D X-rays, and an osteoporosis device providing instant bone mineral density readings for patients. Additionally, they are working on a portable digital strip reader for immunoassay applications. Formerly known as In Vivo Medical Diagnostics, Inc., the company officially adopted its current name in 2005. Its operations are headquartered in Inverness, United Kingdom.
Share Price
$0.0007
Last synced: 2025-09-02
Market Cap
$42.26K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
GB
Trade In Veritas Medical Diagnostics, Inc. (IVME)

Category

Financial Services
P/E ratio for In Veritas Medical Diagnostics, Inc. (IVME)
P/E ratio as of 2026 TTM: 0
According to In Veritas Medical Diagnostics, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for In Veritas Medical Diagnostics, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Clone Algo Technologies Inc. Clone Algo Technologies Inc.
Clone Algo Technologies Inc.
CATI.US
 - -
US
Worldwide Webb Acquisition Corp. Worldwide Webb Acquisition Corp.
Worldwide Webb Acquisition Corp.
WWAC.US
 - -
US
Gushen, Inc. Gushen, Inc.
Gushen, Inc.
GSHN.US
 - -
CN
Apollo Strategic Growth Capital Apollo Strategic Growth Capital
Apollo Strategic Growth Capital
APSG.US
 - -
US
Digital World Acquisition Corp. Digital World Acquisition Corp.
Digital World Acquisition Corp.
DWAC.US
 - -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.